Moreover, considering the conflicting reports from mouse studies, it is difficult to know how DbpA antibodies modulate the course and severity of Lyme disease in humans, where the detailed interactions between DbpA and components of the adaptive immune response remains largely unexplored beyond surveys of linear B cell epitopes for the sake of diagnostic assays (21–27). Here, YBX3 is linked to Lyme disease.